OTC Healthcare in Poland
Euromonitor International's OTC Healthcare in Poland market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 91 | Publication date: Oct 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
The growth slows down
In 2006 growth in the OTC healthcare market was lower than the review period average. Manufacturers blame the weather for tempered sales of products such as analgesics and cough and cold remedies, due to a lower number of infections. Furthermore, per capita consumption of medicaments in Poland is among the highest in Europe, and room for growth is limited.
Multinationals lead
Multinationals such as US Pharmacia, GlaxoSmithKline or Bayer lead in sales of OTC healthcare products in Poland. Heavyweight players gained leading positions through acquisition and organic growth. In 2006, the leading Lithuanian drugs manufacturer took over domestic Jelfa for PLN630 million.
Producers seek new value added opportunities
Manufacturers are increasingly turning their attention towards new segments, as traditionally very popular analgesics and cough, cold and allergy remedies begin to mature. Products based on natural ingredients, more intensified versions of existing brands, niches within vitamins and dietary supplements or medicated skin care are areas of particular interest for manufacturers. Digestive remedies appeal to an increasing number of consumers, as relatively new products within the OTC healthcare environment.
Advertising is a key
Advertising plays a particularly important role in attracting consumers within the OTC healthcare environment. Demand is strongly dependant on advertising support. OTC players were among the highest television advertising spenders in 2006. The television advertising expenditure of US Pharmacia was the eight highest in terms of television spending. GlaxoSmithKline also ranked among the largest television advertisers.
Banned Internet sales
The better availability of products is crucial for increased sales. Internet sales represented one of the fastest growing distribution channels, but the Polish Chamber of Deputies banned Internet sales of OTC drugs. In addition, the adverting of drugstores was banned. Representatives of e-pharmacies, however, declare that they will run business on the basis of European Union law, which permits drug sales via the Internet.
Good prospects for core OTC categories
Strong growth is anticipated for the Polish OTC market, with particularly substantial gains for the high value, core categories of analgesics, vitamins and dietary supplements and cough, cold and allergy remedies. Growth will be underpinned by rapid retail development, increasing product availability and affordability as a result. Digestive remedies and smoking cessation aids will see the most dynamic growth, although the latter will still remain a niche product, as many smokers in Poland still have little or no real interest in giving up this particular pleasure.
Table of contents
OTC HEALTHCARE IN POLAND : MARKET INSIGHT
EXECUTIVE SUMMARY
The growth slows down
Multinationals lead
Producers seek new value added opportunities
Advertising is a key
Banned Internet sales
Good prospects for core OTC categories
KEY TRENDS AND DEVELOPMENTS
Ageing population means more opportunities
Ambitious domestic companies despite strong pressure of multinationals
Civilization diseases affect consumers’ decisions
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 10 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - POLAND
AFLOFARM FARMACJA POLSKA SP Z OO - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Aflofarm Farmacja Polska sp z oo: Key Facts
Summary 3 Aflofarm Farmacja Polska sp z oo: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Aflofarm Farmacja Polska sp z oo: Competitive Position 2006
GRUPA MASPEX WADOWICE - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Maspex Sp zoo: Key Facts
Summary 6 Maspex Sp zoo: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Maspex Sp zoo: Competitive Position 2006
HERBAPOL WROCLAW SA - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Herbapol Wroclaw SA Key Facts
Summary 9 Herbapol Wroclaw SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Herbapol Wroclaw SA: Competitive Position 2006
JELFA SA - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Jelfa SA: Key Facts
Summary 12 Jelfa SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Jelfa SA: Competitive Position 2006
POLPHARMA SA - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Polpharma SA: Key Facts
Summary 15 Polpharma SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 Polpharma SA: Competitive Position 2006
ANALGESICS IN POLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2001-2006
Table 12 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 13 Herbal vs Standard Topical Analgesics 2001/2006
Table 14 Analgesics Company Shares by Retail Value 2002-2006
Table 15 Analgesics Brand Shares by Retail Value 2003-2006
Table 16 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN POLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 20 Sales of Decongestants by Type: Value 2001-2006
Table 21 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 24 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN POLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 29 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 30 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 31 Herbal vs Standard Digestive Remedies 2001/2006
Table 32 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 33 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN POLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 36 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 37 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 38 Herbal vs Standard Medicated Skin Care 2001/2006
Table 39 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 40 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 41 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 42 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 43 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 44 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN POLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 47 Sales of Vitamins by Type: Value 2001-2006
Table 48 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 49 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 50 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 51 Vitamins Brand Shares by Retail Value 2003-2006
Table 52 Sales of Dietary Supplements by Type: Value 2001-2006
Table 53 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 54 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 55 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN POLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 57 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 58 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 59 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 60 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 61 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 62 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
EYE CARE IN POLAND
HEADLINES
SECTOR DATA
Table 64 Sales of Eye Care by Subsector: Value 2001-2006
Table 65 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 66 Eye Care Company Shares by Retail Value 2002-2006
Table 67 Eye Care Brand Shares by Retail Value 2003-2006
Table 68 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 69 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN POLAND
HEADLINES
ADULT MOUTHCARE IN POLAND
HEADLINES
CALMING AND SLEEPING PRODUCTS IN POLAND
HEADLINES
WOUND TREATMENTS IN POLAND
HEADLINES
SECTOR DATA
Table 70 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 71 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 72 Wound Treatments Company Shares by Retail Value 2002-2006
Table 73 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 74 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 75 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011